Sabeen Mekan | Chief Medical Officer
Zymeworks Inc

Sabeen Mekan, Chief Medical Officer, Zymeworks Inc

Dr. Mekan joined Zymeworks in April 2025 and serves as our Senior Vice President and Chief Medical Officer. Dr. Mekan previously served as Executive Director, Global Development Lead for the lung and gastrointestinal cancer franchises with Gilead Sciences based in the U.S. Prior to Gilead, she was the Senior Medical Director, Oncology R&D at Daiichi Sankyo U.S. responsible as global clinical development lead for two antibody-drug conjugates. She began her pharmaceutical career as a Medical Director with Bristol-Myers Squibb with a focus on immune-oncology. Before joining the pharmaceutical industry, she served as an Assistant Professor at Hofstra North Shore LIJ School of Medicine and Attending Hematologist/Oncologist at North Shore Long Island Jewish Hospital in New York City. Dr. Mekan completed her residency in Internal Medicine at the University of Cincinnati, OH, and a fellowship in Hematology and Oncology at the Staten Island University Hospital of Northshore-LIJ Health System (now Northwell Health). She is board-certified in Internal Medicine, Oncology and Hematology and has authored numerous publications.

Appearances:



Festival of Biologics Day 2 @ 15:40

Panel Discussion: The Next Wave of Oncology Biologics: Combination Strategies and Resistance

  • Rational design of combination approaches (bispecifics, ADCs, immunotherapies) to overcome resistance
  • Biomarker strategies for patient stratification in an increasingly crowded pipeline
  • Translating solid tumor microenvironment insights into more effective biologic therapies
last published: 18/Nov/26 17:29 GMT

back to speakers

Get involved at Festival of Biologics USA 2027

 

 

TO SPONSOR


Nicholas Matthews

Nicholas.Matthews@terrapinn.com

 

 

TO SPEAK


Jack Beard
Jack.Beard@terrapinn.com

 

MARKETING & PRESS


Ollie McDaid

Ollie.Mcdaid@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.